Jonathan Fleischmann

1.6k total citations
40 papers, 1.1k citations indexed

About

Jonathan Fleischmann is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Jonathan Fleischmann has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Rheumatology. Recurrent topics in Jonathan Fleischmann's work include Bladder and Urothelial Cancer Treatments (12 papers), Renal cell carcinoma treatment (7 papers) and Urinary Bladder and Prostate Research (5 papers). Jonathan Fleischmann is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Renal cell carcinoma treatment (7 papers) and Urinary Bladder and Prostate Research (5 papers). Jonathan Fleischmann collaborates with scholars based in United States, Netherlands and Australia. Jonathan Fleischmann's co-authors include William J. Catàlona, Seth E. Lerner, Heinz Reichmann, Amy N.B. Johnston, Alan Mackay‐Sim, Antje Haehner, Birgit Herting, George D. Mellick, Henk W. Berendse and Peter A. Silburn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Radiology.

In The Last Decade

Jonathan Fleischmann

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Fleischmann United States 15 451 331 283 199 169 40 1.1k
Virpi V. Smith United Kingdom 20 119 0.3× 636 1.9× 374 1.3× 160 0.8× 31 0.2× 34 1.4k
C. Herberhold Germany 16 443 1.0× 591 1.8× 246 0.9× 98 0.5× 43 0.3× 73 1.1k
S. Lindemann Germany 18 60 0.1× 215 0.6× 299 1.1× 51 0.3× 100 0.6× 50 1.3k
Chung‐Feng Hwang Taiwan 21 154 0.3× 428 1.3× 260 0.9× 163 0.8× 105 0.6× 72 1.2k
Mortaza Bonyadi Iran 19 120 0.3× 157 0.5× 651 2.3× 194 1.0× 125 0.7× 93 1.3k
Noriyoshi Sueyoshi Japan 14 98 0.2× 364 1.1× 257 0.9× 32 0.2× 33 0.2× 36 898
Myung Woul Han South Korea 18 58 0.1× 175 0.5× 245 0.9× 71 0.4× 111 0.7× 40 811
Taku Yamashita Japan 22 447 1.0× 564 1.7× 227 0.8× 81 0.4× 106 0.6× 143 1.4k
Izumi Honda Japan 16 210 0.5× 168 0.5× 255 0.9× 21 0.1× 95 0.6× 36 803
Tetsuro Wada Japan 15 172 0.4× 204 0.6× 70 0.2× 206 1.0× 20 0.1× 63 717

Countries citing papers authored by Jonathan Fleischmann

Since Specialization
Citations

This map shows the geographic impact of Jonathan Fleischmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Fleischmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Fleischmann more than expected).

Fields of papers citing papers by Jonathan Fleischmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Fleischmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Fleischmann. The network helps show where Jonathan Fleischmann may publish in the future.

Co-authorship network of co-authors of Jonathan Fleischmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Fleischmann. A scholar is included among the top collaborators of Jonathan Fleischmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Fleischmann. Jonathan Fleischmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleischmann, Jonathan, et al.. (2017). PERFORMANCE ANALYSIS OF CONSTANT SPEED LOCAL OBSTACLE AVOIDANCE CONTROLLER USING AN MPC ALGORITHM ON GRANULAR TERRAIN. SAE technical papers on CD-ROM/SAE technical paper series. 1. 1 indexed citations
2.
Haehner, Antje, Sanne Boesveldt, Henk W. Berendse, et al.. (2009). Prevalence of smell loss in Parkinson's disease – A multicenter study. Parkinsonism & Related Disorders. 15(7). 490–494. 302 indexed citations
3.
Serels, Scott & Jonathan Fleischmann. (1997). Biologic response modifiers in the management of superficial bladder cancer. World Journal of Urology. 15(2). 96–102. 1 indexed citations
4.
Fleischmann, Jonathan, et al.. (1996). Intravesical bacille Calmette-Guérin therapy for muscle invasive bladder cancer. Urology. 47(2). 208–211. 10 indexed citations
5.
Bennett, Robert T., Seth E. Lerner, Harvey C. Taub, Janice P. Dutcher, & Jonathan Fleischmann. (1995). Cytoreductive Surgery for Stage IV Renal Cell Carcinoma. The Journal of Urology. 32–34. 2 indexed citations
6.
Fleischmann, Jonathan. (1994). CALCIUM CHANNEL ANTAGONISTS IN THE TREATMENT OF INTERSTITIAL CYSTITIS. Urologic Clinics of North America. 21(1). 107–111. 8 indexed citations
7.
Lerner, Seth E., Joan G. Jones, & Jonathan Fleischmann. (1994). MANAGEMENT OF RECURRENT PENILE CANCER FOLLOWING PARTIAL OR TOTAL PENECTOMY. Urologic Clinics of North America. 21(4). 729–737. 11 indexed citations
8.
Fleischmann, Jonathan, et al.. (1993). Management of superficial transitional cell carcinoma of the bladder.. PubMed. 11(4). 193–204. 8 indexed citations
9.
Seltzer, S E, et al.. (1992). Marketing CT and MR imaging services in a large urban teaching hospital.. Radiology. 183(2). 529–534. 12 indexed citations
10.
Fleischmann, Jonathan, et al.. (1991). Clinical and Immunological Response to Nifedipine for the Treatment of Interstitial Cystitis. The Journal of Urology. 146(5). 1235–1239. 37 indexed citations
11.
Fleischmann, Jonathan, et al.. (1991). Measurement and partial characterization of an interleukin-2 inhibitor (IL-2-IN) in human urine.. PubMed. 4(2). 73–80. 1 indexed citations
12.
Fleischmann, Jonathan, et al.. (1990). Synchronous, primary bilateral lymphoma of testes. Urology. 36(2). 186–188. 5 indexed citations
13.
Fleischmann, Jonathan, et al.. (1989). Measurement of Serum Interleukin-2 Activity. Immunological Investigations. 18(5). 713–722. 2 indexed citations
14.
Fleischmann, Jonathan, et al.. (1989). Urinary Interleukin-2 Inhibition in Patients with Cystitis. Immunological Investigations. 18(6). 825–831. 8 indexed citations
15.
Fleischmann, Jonathan. (1988). Biologic Response Modifiers and Urologic Malignancies. Surgical Clinics of North America. 68(5). 1125–1145. 3 indexed citations
16.
Fleischmann, Jonathan, et al.. (1988). Interleukin-2 self-association. Biochemical and Biophysical Research Communications. 152(2). 879–885. 17 indexed citations
17.
Fleischmann, Jonathan, Zahra Toossi, & Jerrold J. Ellner. (1987). Clinical Response to Intravesical BCG Correlated with Urine Acidity and Consistent Interleukin-2 (IL-2) Production. The Journal of Urology. 137(6). 2 indexed citations
18.
Fleischmann, Jonathan, William J. Catàlona, William R. Fair, Warren D.W. Heston, & Mani Menon. (1983). Lack of Value of Radioimmunoassay for Prostatic Acid Phosphatase as a Screening Test for Prostatic Cancer in Patients with Obstructive Prostatic Hyperplasia. The Journal of Urology. 129(2). 312–314. 12 indexed citations
19.
Catàlona, William J., Jonathan Fleischmann, & Mani Menon. (1983). Pelvic Lymph Node Status as Predictor of Extracapsular Tumor Extension in Clinical Stage B Prostatic Cancer. The Journal of Urology. 129(2). 327–329. 13 indexed citations
20.
Fleischmann, Jonathan, et al.. (1981). Embryonal Rhabdomyosarcoma of the Genitourinary Organs. The Journal of Urology. 126(3). 389–391. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026